Cecilia Zavala-Tecuapetla

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Acinetobacter Baumannii

Angiotensin Converting Enzyme

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Cecilia Zavala-Tecuapetla, Hiram Luna-Munguia, María-Leonor López-Meraz, Manola Cuéllar-Herrera
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence. International journal of molecular sciences 23 (24) (2022)
Cecilia Zavala-Tecuapetla, Hiram Luna-Munguia, María-Leonor López-Meraz, Manola Cuéllar-Herrera
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence. International journal of molecular sciences 23 (24) (2022)
Cecilia Zavala-Tecuapetla, Hiram Luna-Munguia, María-Leonor López-Meraz, Manola Cuéllar-Herrera
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence. International journal of molecular sciences 23 (24) (2022)
Cecilia Zavala-Tecuapetla, Hiram Luna-Munguia, María-Leonor López-Meraz, Manola Cuéllar-Herrera
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence. International journal of molecular sciences 23 (24) (2022)
Cecilia Zavala-Tecuapetla, Joaquín Manjarrez-Marmolejo, Josué Orlando Ramírez-Jarquín, Claudia Verónica Rivera-Cerecedo
Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling. Brain sciences 12 (5) (2022)
Cecilia Zavala-Tecuapetla, Manola Cuéllar-Herrera, Hiram Luna-Munguia
Insights into Potential Targets for Therapeutic Intervention in Epilepsy. International journal of molecular sciences 21 (22) (2020)